|
|
|
|
|
|
|
|
|
|
|
24.06.25 - 00:45
|
GENOMMA LAB INTERNACIONAL ANNOUNCES TWELFTH DIVIDEND PAYMENT (PR Newswire)
|
|
|
MEXICO CITY, June 23, 2025 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Company"), one of the leading pharmaceutical and personal care product companies in Mexico with an expanding international presence, informs that the Company filed a......
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
20.04.25 - 17:30
|
In The Holiday Shortened Easter Week, These Large-Cap Stock Were Top Performers (Apr 14-Apr 18): Are These In Your Portfolio? (Benzinga)
|
|
|
Top performers last week: ServiceTitan, Summit Therapeutics, YPF, Eli Lilly, MicroStrategy, America Movil, Ericsson, Insmed, Diamondback, Neurocrine Biosciences.
read more...
|
|
|
11.04.25 - 10:18
|
OncoZenge enters licensing agreement with Avernus Pharma for BupiZenge™ in the GCC Region (Cision)
|
|
|
OncoZenge AB (publ) [”OncoZenge” or the "Company”] announces that the Company and Avernus Pharma General Trading LLC (“Avernus”), a pharma marketing company from the UAE, have signed an exclusive agreement to license BupiZenge™ (Bupivacaine oral lozenges) for commercialization and distribution in the Gulf Cooperation Council (GCC) region.
Background
The licensing agreement entails that Avernus will be the exclusive distributor of BupiZenge™ in the GCC region, including Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, and the UAE, pending successful completion of the BupiZenge™ phase 3 trial and...
|
|
|
|
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
